Related Experiment Video
Updated: Aug 23, 2026

Cell-Specific Paired Interrogation of the Mouse Ovarian Epigenome and Transcriptome
Published on: February 24, 2023
Structural characterization of three novel rat OKL38 transcripts, their tissue distributions, and their regulation by
Choon Kiat Ong1, Chuan Young Ng, Caine Leong
1Laboratory of Molecular Endocrinology, Division of Cellular and Molecular Research, National Cancer Centre of Singapore, 11 Hospital Drive, Singapore 169610.
Abstract:
We previously identified a novel pregnancy-induced growth inhibitory gene, OKL38. To develop a rat model for further characterization of OKL38's role in the initiation and progression of breast and ovarian cancer, we now report the cloning and characterization of three novel rat OKL38 cDNAs that are derived through alternative splicing and differential promoter usage. These three transcripts differ in their 5' untranslated regions but share a common open reading frame that encoded for a 52-kDa protein. OKL38 is mapped to chromosome 19, spanning a region of approximately 15 kb, and contains eight exons. Differential expression of these three rat OKL38 transcripts was observed in liver, kidney, ovary, mammary gland, and uterus. In situ hybridization localized the rat OKL38 transcripts to the luminal epithelial cells of the rat mammary gland and to the granulosa cells in the rat ovary. In vivo studies showed that the RtOKL38-2.0 transcript and protein were regulated by human chorionic gonadotropin in the rat mammary gland and ovary. Importantly, overexpression of RtOKL38-enhanced green fluorescence protein fusion protein in Buffalo rat liver cells resulted in growth inhibition and cell death. Our present findings suggest that OKL38 may function as an effector for human chorionic gonadotropin protection against mammary carcinogenesis, and the availability of the three rat OKL38 cDNAs may help to elucidate the possible role of OKL38 in cellular growth, differentiation, and carcinogenesis.
Insights
Researchers identified three novel rat OKL38 gene variants, crucial for understanding breast and ovarian cancer. These variants, regulated by hormones, inhibit cell growth, suggesting a protective role against mammary carcinogenesis.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- OKL38 is a novel, pregnancy-induced gene with growth inhibitory functions.
- Understanding OKL38's role in breast and ovarian cancer requires a suitable animal model.
Purpose of the Study:
- To clone and characterize novel rat OKL38 cDNAs for developing a rat model.
- To investigate the role of OKL38 in cancer initiation and progression.
Main Methods:
- Cloning and characterization of three rat OKL38 cDNAs.
- Gene mapping to chromosome 19 and exon analysis.
- Differential expression analysis using in situ hybridization and in vivo studies.
- Functional study involving overexpression in Buffalo rat liver cells.
Main Results:
- Identified three rat OKL38 transcripts differing in 5' untranslated regions but sharing a common coding sequence for a 52-kDa protein.
- Demonstrated differential expression of OKL38 transcripts in various rat tissues, including mammary gland and ovary.
- Showed regulation of a specific transcript (RtOKL38-2.0) by human chorionic gonadotropin in vivo.
- Confirmed growth inhibition and cell death upon overexpression of RtOKL38 in rat liver cells.
Conclusions:
- OKL38 may act as an effector for human chorionic gonadotropin in protecting against mammary carcinogenesis.
- The characterized rat OKL38 cDNAs provide a valuable tool for studying cellular growth, differentiation, and carcinogenesis.
More Related Videos
08:00Defining the Program of Maternal mRNA Translation during In vitro Maturation using a Single Oocyte Reporter Assay
Published on: June 16, 2021
10:24A High Throughput in situ Hybridization Method to Characterize mRNA Expression Patterns in the Fetal Mouse Lower Urogenital Tract
Published on: August 19, 2011
Related Concept Videos
Regulation of Expression at Multiple Steps
General Transcription Factors